Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
89,116,466
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
8,248,532
-
Shares change
-
-1,192,843
-
Total reported value, excl. options
-
$16,827,020
-
Value change
-
-$3,796,505
-
Put/Call ratio
-
35%
-
Number of buys
-
21
-
Number of sells
-
-26
-
Price
-
$2.04
Significant Holders of ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) as of Q4 2024
71 filings reported holding RMTI - ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share as of Q4 2024.
ROCKWELL MEDICAL, INC. - Common Stock, par value $0.0001 per share (RMTI) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,248,532 shares
of 89,116,466 outstanding shares and own 9.3% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (3,043,678 shares), VANGUARD GROUP INC (1,203,910 shares), GLOBEFLEX CAPITAL L P (743,256 shares), MARSHALL WACE, LLP (596,359 shares), RENAISSANCE TECHNOLOGIES LLC (442,350 shares), GEODE CAPITAL MANAGEMENT, LLC (320,416 shares), BlackRock, Inc. (254,395 shares), AMERIPRISE FINANCIAL INC (221,955 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (144,428 shares), and ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (106,135 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.